Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E test: a novel technique for antimicrobial susceptibility testing

H S Sader1, A C Pignatari

  • 1Department of Infectious and Parasitic Diseases of the Escola Paulista de Medicina, São Paulo, SP Brasil.

Sao Paulo Medical Journal = Revista Paulista De Medicina
|October 1, 1994
PubMed
Summary

The E test provides a reliable method for determining antimicrobial susceptibility. This study evaluated its effectiveness for key bacterial pathogens against various drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oritavancin <i>in vitro</i> activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019).

Journal of chemotherapy (Florence, Italy)·2023
Same author

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.

Antimicrobial agents and chemotherapy·2023
Same author

Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015-2018).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.

Antimicrobial agents and chemotherapy·2019
Same author

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.

Diagnostic microbiology and infectious disease·2018
Same author

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015).

Diagnostic microbiology and infectious disease·2018

Area of Science:

  • Microbiology
  • Clinical Pharmacy
  • Infectious Diseases

Background:

  • Accurate antimicrobial susceptibility testing is crucial for effective treatment of bacterial infections.
  • The E test is a commercially available method for determining minimum inhibitory concentrations (MICs).

Purpose of the Study:

  • To evaluate the applicability and performance of the E test for antimicrobial susceptibility testing.
  • To assess the E test's utility in determining MICs for specific bacterial pathogens.

Main Methods:

  • Literature review on the E test methodology.
  • In-house susceptibility testing of Xanthomonas maltophilia, Streptococcus pneumoniae, and Streptococcus viridans group using the E test.
  • Evaluation against eight different antimicrobial agents.

Related Experiment Videos

Main Results:

  • The E test demonstrated applicability in determining antimicrobial susceptibility for the tested bacteria.
  • Results from the E test provided minimum inhibitory concentrations for various drug-bacteria combinations.

Conclusions:

  • The E test is a viable method for routine antimicrobial susceptibility testing in clinical laboratories.
  • Further studies are warranted to establish comprehensive E test breakpoints for emerging pathogens.